Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
BMEA is expected to report earnings to fall 32.47% to -34 cents per share on November 04
Q3'25
Est.
$-0.34
Q2'25
Beat
by $0.03
Q1'25
Beat
by $0.12
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.03
The last earnings report on August 05 showed earnings per share of -50 cents, beating the estimate of -54 cents. With 387.66K shares outstanding, the current market capitalization sits at 91.64M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BMEA showed earnings on August 05, 2025. You can read more about the earnings report here.